MAP kinase: it's been longer than fifteen minutes.

Tight junctions in the testis: new perspectives. Philos Trans R Soc Lond B Biol Sci (2010) 1.16

Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy. Drug Resist Updat (2009) 1.12

RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity. J Biol Chem (2010) 1.06

ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. Int J Cancer (2011) 1.00

Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin. Oncogene (2009) 0.94

Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression. Mol Cell Proteomics (2010) 0.89

Effect of branched-chain amino acid supplementation during unloading on regulatory components of protein synthesis in atrophied soleus muscles. Eur J Appl Physiol (2011) 0.86

Mechano-transduction in periodontal ligament cells identifies activated states of MAP-kinases p42/44 and p38-stress kinase as a mechanism for MMP-13 expression. BMC Cell Biol (2010) 0.86

Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Res (2010) 0.84

Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in rats. Neuroscience (2012) 0.83

Specifically targeting ERK1 or ERK2 kills melanoma cells. J Transl Med (2012) 0.82

Pharmacological analyses of protein kinases regulating egg maturation in marine nemertean worms: a review and comparison with Mammalian eggs. Mar Drugs (2010) 0.77

Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period. Cell Cycle (2016) 0.75

Induction of breast cancer in wild type p53 cells by BRCA1-IRIS overexpression. Hawaii Med J (2010) 0.75